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DO WE KNOW THE EDUCATIONAL NEEDS OF NURSES WORKING WITH
PHYSICIANS WHO REFER PATIENTS TO TRANSPLANT CENTERS?
Tierney, D.K.1, Schmit-Pokorny, K.2, Sorensen, S.3, McDermott, K.4,
Devine, H.5 1Stanford University Medical Center, Stanford, CA; 2Uni-
versity of Nebraska Medical Center, Omaha, NE; 3MD Anderson Can-
cer Center, Houston, TX; 4Dana Farber Cancer Institute, Boston, MA;
5Arthur G. James Cancer Hospital and Richard J. Solove Research
Institute, Columbus, OH.
Topic: The educational needs of nurses working with physicians
referring patients for hematopoietic cell transplantation (HCT).
Purpose: Develop and conduct a survey of referring nurses to
determine their educational needs and the most effective teaching
methodologies to address these identiﬁed needs.
Interventions: Transplant Research and Education Initiatives in
Nursing (TREIN) consists of ﬁve nurses from geographically dis-
tinct United States transplant centers whose goal is to develop and
implement educational and research programs for the beneﬁt of
nurses and the patients they serve. TREIN is supported by an
unrestricted educational grant from AnorMED. TREIN’s ﬁrst
project is to develop an understanding of the educational needs of
referring nurses. To date, we have developed and conducted a pilot
survey. Each member of TREIN interviewed two referring nurses.
Using the ﬁndings from this pilot survey, a questionnaire has been
developed to be used in a comprehensive survey of referring
nurses.
Findings: The pilot survey identiﬁed a number of factors that
were considered in the development of the ﬁnal questionnaire. One
of our ﬁrst challenges was identifying the referring nurse. While
each transplant center has data on referring physicians, identifying
the nurse or nurses in the practice was cumbersome. Communi-
cation between the HCT center and the referring practice was
usually done between the HCT coordinator or physician directly
to the referring physician. Referring nurses did not usually receive
direct information from the HCT center although direct commu-
nication was desired. Nine of ten referring nurses interviewed
identiﬁed learning needs. The most common learning need was for
basic medical and nursing education regarding the HCT process.
Discussion: Referring nurses assume care for HCT recipients at
many points across the treatment and recovery continuum and may
have little to no formal education regarding HCT. It is our hope
that by identifying not only the learning needs of referring nurses
but also the most appropriate teaching methodologies, TREIN
will be able to reach out to referring nurses to address these unmet
educational needs. We believe that by establishing a closer rela-
tionship with referring nurses and assisting them with their trans-
plant related educational needs, the care of HCT patients will be
enhanced and a smoother transition of care for HCT patients
before and after transplantation will be facilitated.
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HEMATOPOIETIC STEM CELL TRANSPLANT NURSING: COMPETENCY-
BASED TRAINING
Rodriguez, A.L.1, Tokarz-Vancura, L.1 1Northwestern Memorial Hos-
pital, Chicago, IL.
Purpose
Stem cell transplantation (SCT) is a growing specialty in oncol-
ogy and in immunotherapy. Although there is an extensive data-
base on the medical aspects of SCT, there is a signiﬁcant gap in the
literature relating to clinical training guidelines for the orientation
of new transplant nurses. Furthermore, inconsistencies were iden-
tiﬁed in the institution’s current orientation program which fo-
cused considerably on technical skill training.
The development of a systematic, competency based orientation
program will maximize the learning and teaching opportunities
ensuring comprehensive cognitive and procedural skill training for
the new SCT nurses. The researchers identiﬁed the need to de-
velop self-directed learning modules and quizzes to develop nurses’
clinical inquiry and problem solving skills. The need to improve
the process for stem cell reinfusion skill training to ensure staff’s
technical competency was also identiﬁed. Lastly, outdated policies
and competency checklists will be revised to reﬂect the new com-
petency-based orientation training.
Interventions
A comprehensive literature search was conducted to establish the
lack of literature related to competency-based training programs in
stem cell transplant nursing. Benchmarking with comparable
transplant centers in the country was conducted to establish indus-
try best practices. A learning needs-assessment was conducted to
establish areas in the SCT orientation process requiring improve-
ments.
Evaluation
This project identiﬁed best practices in the orientation of a new
SCT nurse and identiﬁed several phases:
I. Basic stem cell transplant didactic training
II. Intake process observation
III. Stem cell harvest observation
IV. Stem cell cryopreservation observation
V. Stem cell reinfusion training
VI. Self directed readings and learning modules
VII. Annual SCT nursing competency evaluation
This competency-based nursing orientation program will ensure
clinical and cognitive core competencies to prepare new SCT
nurses to effectively and safely care for the clinically complex and
often critically ill SCT patients.
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ANALYSIS OF OUTCOMES FOR VASCATH INSERTION FOR PAEDIATRIC
PERIPHERAL BLOOD STEM CELL COLLECTION: A QUEENSLAND EXPE-
RIENCE
Shergold, J.1, Travers, R.1, Shelley, R.1 1Royal Children’s Hospital-
Brisbane, Brisbane, Queensland, Australia.
Haematopoietic stem cell transplantation is now a standard pro-
cedure used for many paediatric oncology conditions. The stem
cells can be collected from 3 different sources, bone marrow, cord
blood and from peripheral blood.
Peripheral blood stem cells are harvested following stem cell
mobilisation into the peripheral blood. Standard practice in adult
units is to insert a large bore or 14Gauge peripheral cannula.
However in children this is not practical, so another option is
required. The use of standard central venous catheters (CVC) is
not possible due to the large ﬂow rate required which can collapse
the standard CVC. It is the standard of practise at the Royal
Children’s Hospital to insert an apheresis catheter to the jugular or
subclavian veins. This catheter is inserted and remains insitu until
the peripheral blood stem cell collection is completed. There is
little data published on the complications arising from this practice
in paediatrics unless inserted in the femoral vein. This paper will
discuss our institutional practice and current outcomes noted in
relation to peripheral blood stem cell collections and the use of
large rigid apheresis catheters.
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ESTABLISHMENT OF A LONG-TERM ALLOGENEIC BLOOD AND MAR-
ROW PROGRAM FOR EARLY DETECTION OF COMPLICATION AND MEA-
SURING OUTCOMES
Trevino, C.M.1, Neumann, J.1, Couriel, D.1, Popat, U.1, Hsu, Y.1
1University of Texas M. D. Anderson Cancer Center, Houston, TX.
Almost sixty percent of the 613 patients transplanted at our
center last year received allogeneic blood or marrow transplanta-
tion. Allogeneic BMT complications are most prevalent in the ﬁrst
100 days, but late infections and chronic graft versus host disease
frequently occur after patients leave our comprehensive cancer
center at day 100. Establishing a thorough, comprehensive and
central computer accessible patient assessment will enable practi-
tioners to phone triage problems with community healthcare pro-
viders and identify changes during follow-up visits for prevention,
early detection of complication and prompt referrals.
At our center the patient’s initial BMT physician remains in-
volved in the care throughout the transplant process and follow-up.
Referrals to our GVHD clinic occur as deemed appropriate by the
clinic physician. Capture of the overall program incidence and
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severity of complications like GVHD can be problematic. We have
assigned one full-time Nurse Practitioner (NP) to follow the allo-
geneic patients from day 80-100 to the end of the ﬁrst year after
transplantation. The LTFU programNP coordinates care with the
patient’s clinic physician and Physician Assistant (PA). An extensive
assessment is performed around the time the patient will be leaving
the transplant center. Baseline data and outcome tracking will
include incidence and severity of chronic graft vs. host disease,
infections, endocrine and nutritional disorders, quality of life, and
survival. Interesting trends have been noted and will be reported.
Information about assessment tools and outcomes will be shared.
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BK VIRUS: A PROBLEM IN THE PEDIATRIC BONE MARROW TRANS-
PLANT PATIENT
Van Stelle, J.L.1, Sickel, A.D.1, Hild, E.1, Kissane, R.1, Bathurst, J.1,
Quinones, R.1, Giller, R.H.1, Peltz, A.C.1, Christensen, M.J.1,
Adams, J.1 1The Children’s Hospital Denver, Denver, CO.
BK Virus is a polyomavirus that infects a large percentage of the
human population; however, clinically signiﬁcant infections de-
velop almost exclusively in immunocompromised patients. BK Vi-
rus is one of the viruses that may be associated with hemorrhagic
cystitis (HC) in bone marrow transplant (BMT) patients. Recently
at The Children’s Hospital in Denver there was concern that the
incidence of BK virus might be increasing in our BMT population.
Of the 307 patients transplanted from 1/94-8/06 (144 autologous
and 163 allogeneic), 60 developed HC, nine of these 60 in the last
year. BK virus was documented by urine PCR in 37; 6 had a
documented negative; and 17 had no documented BK testing.
Routine testing at our institution did not begin until 1999 and is
only done if a patient develops clinical HC. Evaluation of our data
currently does not support an increased incidence. It appears pa-
tients who are more severely immunocompromised, whether from
their disease or treatment regimen, were at greater risk for being
positive for BK virus-associated HC. An explanation of our in-
creased numbers is we are treating greater number of patients who
are more severely immunocompromised. In our population all
patients with a positive BK were 4 years or older. Although sex
does not appear to be a signiﬁcant risk factor, it appears clinically
boys had a higher morbidity than girls. Obstruction from clots that
resulted in pain & urine retention was the main complications boys
experienced. Treatment for BK virus is primarily related to symp-
tom management & includes aggressive hydration, pain & bladder
spasm treatment and transfusion support. Emotional support of
patients and family is critical. Cidoﬁvir has shown some efﬁcacy in
treatment of BK viruria. More severe cases have also received
bladder irrigation, prostaglandin instillation &/or hyperbaric oxy-
gen. Our institution is also exploring methods to prevent trans-
mission of the virus such as isolation and improved hand washing
techniques. Nursing management & support of patients and fam-
ilies is key to a successful outcome. This includes initiating a
diagnostic/treatment plan at the ﬁrst sign of HC, facilitating re-
search studies, providing explanations of the drugs and procedures
used to alleviate symptoms, monitoring labs and providing emo-
tional support. Since there are many unanswered questions and no
optimum treatment, we continue to need further research concern-
ing prevention & management of BK virus-associated HC.
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IMPROVING YIELD FROM BLOOD CULTURES FOR TRANSPLANT PA-
TIENTS
Wood, J.M.1, Eilers, J.1, DeVetten, M.1, Freifeld, A.1 1Nebraska Med-
ical Center, Omaha, NE.
Treatment and disease related factors place hematopoietic stem
cell transplant (HSCT) patients at risk for life threatening infec-
tions. Multiple blood cultures are common in the attempt to
identify a causative organism, guide antimicrobial coverage, and
provide for optimum patient outcome. Historically there were
inconsistencies in the number of sets that were drawn and the
number of sites that were accessed for collecting the blood culture
specimens. The goal of this project was to develop an evidenced-
based protocol that would standardize practice for blood cultures
and improve the clinical usefulness of results. Our performance
improvement (PI) team worked with the transplant and infectious
disease physicians to develop the protocol for drawing blood cul-
tures. Staff were educated regarding the new policy and its ratio-
nale. Compliance with the protocol was monitored and variations
in practice were addressed with individual staff members. Three
months of data post protocol implementation (Time 2) were com-
pared with historical data (Time 1). During T1, 96 patients had
314 culture events; during T2, 85 patients had 293 culture events.
The average number of cultures per febrile patient during hospi-
talization in T1 was 4.5 sets, and each febrile patient was cultured
an average of 3.2 days during the hospital stay. In T2, each febrile
patient had an average of 7.4 culture sets drawn during the stay,
and was cultured an average of 3.4 days. In T1, 37% of the time
cultures were obtained from more than one site as compared to
89% in T2. Although the number of culture events did not change
signiﬁcantly, the protocol resulted in an increased number of
positive cultures and infections identiﬁed in febrile patients. This
project demonstrates how a nurse driven initiative can promote
evidenced-based practice change that has the potential to improve
patient outcomes.
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THE SAFETY AND EFFICACY OF PROPHYLACTIC VORICONAZOLE TO
PREVENT FUNGAL INFECTIONS IN PEDIATRIC BLOOD AND MARROW
TRANSPLANT PATIENTS
Zbylut, C.A.1, Frey, M.A.1, Kurtzburg, J.1 1Duke University Medical
Center, Durham, NC; Duke Pediatric Blood and Marrow Transplant
Program, Durham, NC.
Infection is one of the leading causes of morbidity and mortality
in patients undergoing hematopoietic stem cell transplantation.
Increased risk of infection is associated with prolonged neutropenia
and delayed immune reconstitution which are common in recipi-
ents of unrelated donor cord blood or T-cell depleted adult grafts.
In the past, invasive fungal infections were frequent and more
difﬁcult to treat. Aspergillus is commonly seen in immunocompro-
mised patients and is challenging from a nursing care standpoint.
Patients with pulmonary involvement are often febrile with in-
creasing oxygen requirements in addition to having increased num-
bers of medication infusions. Historically, amphotericin B was used
prophylactically to prevent fungal infections. New studies are test-
ing whether voriconazole is superior to other antifungal agents for
prevention and treatment of invasive fungal disease. By compari-
son, voriconazole has fewer side effects than amphotericin B, with
less nephrotoxicity which is advantageous in the transplant setting
with concomitant administration of cyclosporine or tacrolimus.
The use of voriconazole has been associated with a decrease in the
number of Aspergillus cases but a concomitant rise in less serious
infections with azole-resistant candida species. The purpose of this
abstract is to outline the nursing care associated with patients with
invasive fungal disease. Speciﬁc goals will be to describe the clinical
presentation of the patient with fungal disease as well as the
treatment options and associated side effects.
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PROPHYLAXIS OF PNEUMOCYSTIS CARINII PNEUMONIA (PCP) WITH
INHALED PENTAMIDINE IN PEDIATRIC PATIENTS UNDERGOING HE-
MATOPOIETIC STEM CELL TRANSPLANTATION
Zelko, V.S.2, Frey, M.A.2, Kurtzberg, J.2 1Duke University Hospital,
Durham, NC; 2The Duke Pediatric Blood and Marrow Transplant
Program, Durham, NC.
Pneumocystis carinii pneumonia (PCP) is a potentially life
threatening opportunistic infection that occurs in immunosup-
pressed patients. The drug of choice for the treatment and
prevention of this disease is trimethoprim-sulfamethoxazole
(TMP) but alternatives are often needed because of adverse
effects or treatment failure. Pentamidine is one alternative com-
monly used in patients undergoing hematopoietic stem cell
transplantation because, unlike TMP, it is not myelosuppres-
sive. Pentamidine has very low rate of absorption from the
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